Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US......
Drug major Ranbaxy Laboratories said on Monday it has resumed the supply of Atorvastatin calcium tablets, a cholesterol lowering drug, in the US market."Ranbaxy Pharmaceuticals Inc, the US......
Ranbaxy's generic version of Lipitor, which faced recall from the US market last month, could remain missing at the beginning of 2013, if the company fails to resume supplies of the drug by the end......
Drug major Ranbaxy on Friday said it is recalling its generic version of cholesterol-lowering drug Lipitor from the US market leading to temporary disruption in the supply."The company has made a......
After its Paonta Sahib and Dewas units, Ranbaxy’s third and newly commissioned Mohali facility, too, appears to have come under the US regulator’s scanner. After finding deviations from......